2-Bromo-4,5,6,7-tetrahydrobenzo[b]thiophene, 95.0%, 250mg

tert-Butyl (2-amino-1-phenylethyl)carbamate, 95.0%, 1g

3-IODO-2-ISOPROPOXYPYRIDINE, 97.0%, 1g

1,4-Dibromo-2-fluorobenzene>98.0%(GC)25g

Analytical and precision scale Entris® II series Models with internal adjustment, factory calibrated, 0.01 g, 2200 g, BCE2202i-1CEU

Oprozomib, 99.71%, 10mg

6-Amino-4-chloronicotinic acid, 95.0%, 5g

5-Chloro-3-(4-chloro-phenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde, 95.0%, 1g

(R)-tert-Butyl 3-(chloromethyl)pyrrolidine-1-carboxylate, 95.0%, 100mg

(2Z)-2-(hydroxyimino)-3-oxo-N-phenylbutanamide, 5g

11-(Bromomethyl)tricosane, 97%, 5g

2-Iodo-3-methoxyaniline, 95.0%, 1g

Nimustine hydrochloride, 97%, 250mg